$10 million pledge for international collaboration on vaccine research
Published: 09 March 2022
New Zealand is continuing to support the Coalition for Epidemic Preparedness Innovations (CEPI), with a $10 million pledge announced. CEPI is aimed at ending global pandemics, and has a 5-year plan that aims to strengthen the global system for pandemic response and preparedness.
On this page
As members of CEPI, New Zealand directly benefits from global achievements in vaccine research and development and manufacturing capability.
CEPI’s 5-year plan includes:
- being able to develop vaccines for any future pandemic within 100 days of the viral sequence being identified
- developing pan-coronavirus vaccines and therapeutics that would apply across COVID-19 variants and other coronaviruses
- establish networks of global vaccine scientific and manufacturing capacity that can be rapidly utilised in any future pandemic.
CEPI are partners in the COVAX Facility, which plays a vital role in ensuring equitable access to COVID-19 vaccines for all nations in the world. Aotearoa New Zealand also provides active support to COVAX itself, contributing more than $26 million to date.
Shot in the arm for global vaccine development(external link) — Beehive.govt.nz
MBIE media contact
Please note: This content will change over time and can go out of date.